Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperaldosteronism × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Colorectal Neoplasms 6 Breast Neoplasms 5 Lung Neoplasms 4 Endometrial Neoplasms 4 Stomach Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Oropharyngeal Neoplasms 2 Obesity 2 Meningioma 2 Lymphoma, Large B-Cell, Diffuse 2 Esophageal Neoplasms 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pseudomyxoma Peritonei 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Paranasal Sinus Neoplasms 1 Ovarian Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Hyperaldosteronism, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡